A detailed history of Lazard Asset Management LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Lazard Asset Management LLC holds 13,530 shares of QURE stock, worth $96,468. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,530
Previous 129 10388.37%
Holding current value
$96,468
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.78 - $10.12 $50,655 - $135,618
13,401 Added 10388.37%
13,530 $66,000
Q2 2024

Aug 14, 2024

SELL
$4.39 - $5.43 $8,029 - $9,931
-1,829 Reduced 93.41%
129 $0
Q1 2024

May 14, 2024

SELL
$4.82 - $6.93 $5,215 - $7,498
-1,082 Reduced 35.59%
1,958 $9,000
Q4 2023

Feb 14, 2024

BUY
$5.63 - $8.27 $619 - $909
110 Added 3.75%
3,040 $20,000
Q3 2023

Nov 14, 2023

BUY
$6.71 - $11.83 $899 - $1,585
134 Added 4.79%
2,930 $19,000
Q2 2023

Aug 14, 2023

SELL
$11.12 - $22.2 $32,303 - $64,491
-2,905 Reduced 50.96%
2,796 $32,000
Q1 2023

May 15, 2023

BUY
$18.7 - $23.07 $56,025 - $69,117
2,996 Added 110.76%
5,701 $114,000
Q4 2022

Feb 14, 2023

SELL
$18.12 - $27.32 $34,554 - $52,099
-1,907 Reduced 41.35%
2,705 $61,000
Q3 2022

Nov 14, 2022

SELL
$16.98 - $25.54 $194,098 - $291,947
-11,431 Reduced 71.25%
4,612 $86,000
Q2 2022

Aug 09, 2022

BUY
$13.15 - $20.45 $68,380 - $106,340
5,200 Added 47.96%
16,043 $298,000
Q1 2022

May 13, 2022

BUY
$14.54 - $21.5 $110,998 - $164,131
7,634 Added 237.89%
10,843 $195,000
Q4 2021

Feb 09, 2022

SELL
$20.24 - $36.01 $56,631 - $100,755
-2,798 Reduced 46.58%
3,209 $65,000
Q3 2021

Nov 15, 2021

BUY
$26.01 - $38.22 $53,242 - $78,236
2,047 Added 51.69%
6,007 $191,000
Q2 2021

Aug 12, 2021

BUY
$29.97 - $37.17 $60,599 - $75,157
2,022 Added 104.33%
3,960 $121,000
Q1 2021

May 14, 2021

BUY
$29.24 - $42.03 $54,298 - $78,049
1,857 Added 2292.59%
1,938 $65,000
Q4 2020

Feb 11, 2021

BUY
$35.35 - $50.67 $1,484 - $2,128
42 Added 107.69%
81 $2,000
Q2 2020

Aug 13, 2020

BUY
$45.06 - $67.74 $1,757 - $2,641
39 New
39 $1,000
Q3 2018

Nov 13, 2018

SELL
$29.75 - $43.08 $3.41 Million - $4.94 Million
-114,681 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$21.96 - $39.94 $629,900 - $1.15 Million
28,684 Added 33.35%
114,681 $4.33 Million
Q1 2018

May 14, 2018

BUY
$17.1 - $26.61 $1.47 Million - $2.29 Million
85,997 New
85,997 $2.02 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $333M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.